MIR3928

Across TCGA pan-cancer cohorts, MIR3928 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated MIR3928 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR3928 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR3928 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUSC show a favorable association.

HNSC, COAD, and UCEC are the cancer types where MIR3928 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.752	0.568	<.001	144	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	90	view →
UCEC	DFS	Tertile	II,III,IV	0.588	0.842	.002	84	view →
STAD	DFS	Tertile	II,III,IV	0.315	0.718	<.001	72	view →
UVM	OS	Tertile	All	0.220	0.917	<.001	54	view →
THCA	OS	Tertile	All	0.741	0.937	.006	27	view →
KIRC	OS	Tertile	All	0.532	0.684	.017	24	view →
SKCM	DFS	Tertile	IV	0.111	0.694	.004	18	view →
LUSC	OS	Tertile	II,III,IV	1.000	0.454	.026	12	view →
READ	OS	Tertile	III,IV	0.649	0.907	.033	12	view →
PAAD	DFS	Tertile	All	0.590	0.231	.032	9	view →
LIHC	OS	Tertile	All	0.453	0.685	.048	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

MIR3928–HNSC (DFS)

Open the HNSC breakdown →